Oxytocin vs Selank
How Oxytocin and Selank compare — what each is, how strong the human evidence is for each, doses reported in research, the key risks, and 2026 US legal status. No universal winner.
Oxytocin and Selank come up together when people are weighing similar options. Here's the honest side-by-side: what each is, how strong the human evidence is for each, the doses reported in research, the risks, and where each stands with the FDA as of 2026. There's no universal winner — scroll to the by-goal picks for which one fits which goal.
Oxytocin vs Selank, point by point
Every dimension side by side — the honest differences, not a scoreboard.
| Dimension | Oxytocin | Selank |
|---|---|---|
| What it is | Endogenous cyclic nonapeptide hormone and neurotransmitter | Synthetic heptapeptide (a 7-amino-acid analog of the immune peptide tuftsin) |
| Class / category | Nootropic / mental-health | Nootropic / mental-health |
| Evidence tier | Human RCT · Mixed | Human RCT · Helped |
| Studied / approved for | Medical induction or stimulation of labor; Adjunctive management of incomplete or inevitable abortion; Uterine contraction during the third stage of labor and control of postpartum bleeding or hemorrhage | Anxiety / generalized anxiety disorder; Cognitive support and attention; Asthenic and stress-related conditions |
| US regulatory status (2026) | fda approved (as of Jul 2026) — approved for Medical induction or stimulation of labor, Adjunctive management of incomplete or inevitable abortion, Postpartum uterine contraction and bleeding or hemorrhage control | research use only (as of Jul 2026) |
| Doses reported in research | No established study doses | No established study doses |
| Registered trials (ClinicalTrials.gov) | No data | 2 |
| Banned in sport (WADA) | Unknown | Unknown |
| Key risks | Hospital oxytocin has well-characterized, potentially serious obstetric risks and requires monitoring. Excessive uterine stimulation can harm both mother and fetus; prolonged high-dose infusion can cause water intoxication and seizures. The 24-week autism trial found similar adverse-event incidence and severity with intranasal oxytocin and placebo, but that does not establish long-term safety for compounded nasal use or healthy-person social enhancement. | Selank's human safety record comes mainly from its clinical use in Russia as an anxiety drug, where it has been described as well tolerated, non-sedating and free of the dependence that dogs benzodiazepines — a genuine point in its favor. The caveats: the safety data is short-term and mostly from one country, long-term and independent Western data are thin, and US research-chemical vials are unregulated for purity and sterility. |
- Evidence tier: A tier reflects how human the evidence is, not a promise the compound works.
Oxytocin vs Selank: the two molecules
The 2D chemical structures, straight from PubChem — a quick way to see how similar (or not) the two actually are.
Which one fits which goal?
There's no universal winner here — the honest answer depends on what you're after. These picks are framed by goal, and each says why.
If you want an FDA-approved, prescribable option
Leans toward Oxytocin
Oxytocin is FDA-approved (as of Jul 2026); Selank is research use only in the US, so it isn't available as an approved prescription.
References
- 1.Oxytocin Injection, USP prescribing information
- 2.Sikich et al., 2021 - intranasal oxytocin in children and adolescents with autism
- 3.Zhang et al., 2025 - oxytocin dose-response meta-analysis in autism
- 4.Oxytocin - PubChem CID 439302
- 5.FDA - Compounding and the FDA: Questions and Answers
- 6.Selank — indexed research (PubMed, National Library of Medicine)